ReviewThe Pan African medical journal2025
Cervical cancer in Morocco: a literature review on risk factors, prevalence, and healthcare challenges.
Review in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- International Western Radiation Therapy Guidelines Applicability in Low- and Middle-Income Countries for Cervical Cancer Management: A Comparative Survey Example from South and North Border of the Mediterranean Area Countries.Advances in radiation oncology · 2026Article
- Cervico-Vaginal Microbiome Dynamics Across HPV-Driven Lesion Stages in Moroccan Women.Microorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer (CC) stands as the second most prevalent cancer among women in Morocco, with an estimated annual incidence of 2165 cases and over 1199 associated deaths. However, the lack of a comprehensive national registry requires caution in interpreting these figures. This review highlights the examination of the epidemiological profile, diagnostic modalities, risk factors, treatment, and prevention related to CC screening within the context of Morocco. High-risk subtypes of the human papillomavirus (HPV) are the etiological cause of the disease in most cases. Underscoring the urgent need for a thorough understanding of its epidemiological landscape. Other risk factors as age of sexual debut, sexual partners and sexually transmitted infections, immunosuppression, smoking, and parity should be studied comprehensively. Treatment modalities for CC are contingent upon disease staging at diagnosis and the availability of local healthcare resources. Options encompass radical hysterectomy and chemoradiation. The Ministry of Health's endorsement of the vaccine in 2022 marked a significant milestone in combating cancer through prevention and treatment, as it integrated the HPV vaccination into the national vaccination program, targeting girls aged 11 years. Morocco's healthcare landscape underwent significant reforms, culminating in the implementation of compulsory basic medical coverage in 2020 to ensure equitable access to healthcare services for all citizens. Consequently, this proactive approach holds promise for enhancing care standards and substantially curtailing mortality rates attributable to cancer across Morocco in the coming years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.